Serum Institute of India is the vaccine producer that will invest 50 million pounds ($68.24 million) in Oxford Biomedica, one of the COVID-19 vaccine manufacturers...
The Drug Controller General of India (DCGI) has approved the restricted emergency use of the Sputnik V vaccine late Monday night. With this, India now...
Rising Sun Holdings, a company controlled in a personal capacity by Serum Institute of India CEO Adar Poonawalla, announced a transaction on February 10 to acquire a...